Although increased signaling and increased migration are traits that normally would benefit cancer cells, the role of FGFR2 signaling in bladder cancer is not fully understood and the FGFR2b isoform has been suggested to act as a tumor suppressor in the urothelium. The gene discussed is FGFR2; the disease is urinary bladder cancer.